Sage Journals: Discover world-class research

Retricted access

Case report

First published 2022-7

Multiple rechallenges with anti-PD-1 immunotherapy in patients with checkpoint inhibitor-related pneumonitis: A report of two cases

Zheng Yan, Shuna Yao, Junhui Yuan [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025

Machine Learning Model Integrating CT Radiomics of the Lung to Predict Checkpoint Inhibitor Pneumonitis in Patients with Advanced Cancer

François Cousin, Thomas Louis, Pierre Frères [...]

Technology in Cancer Research & Treatment

Retricted access

Case report

First published 2020-1

Acute coronary syndrome and recurrent colitis as immune-related adverse events in a lung cancer patient

Bárbara Cancela-Díez, Félix Gómez-De Rueda, María J Antolinos Pérez [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2020

Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer

Pengfei Cui, Di Huang, Zhaozhen Wu [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2021-1

Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab

Nikhila Kethireddy, Steffi Thomas, Poorva Bindal [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023-10

Atezolizumab-associated myositis in a patient with unresectable hepatocellular carcinoma

Tania Baigi, Erika N Brown, Rodrigo M De La Torre [...]

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2025

Early severe immune-related pneumonitis,hepatitis,and agranulocytosis with radiographic response in sarcomatoid malignant pleural mesothelioma treated with nivolumab and ipilimumab: a case report highlighting dual liver biopsies and rechallenge decision-making

Tomohiro Oba, Katsuhiro Itogawa, Yoko Machida [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2023

A Systematic Review of Clinical Practice Guidelines for Managing Pulmonary Toxicities Caused by Immune Checkpoint Inhibitors: Quality of Treatment Recommendations and Differences in Management Strategies Between Guidelines

Kofi N Donkor, Hyeree Jang, Reena Sail

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2020

Diagnosis and Management of Checkpoint Inhibitor Side Effects in Patients with Bladder Cancer: the Urologist’s Perspective

Neal Shore

Bladder Cancer

Retricted access

Case report

First published 2020-10

Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia

Ali Yılmaz, Cem Mirili, Mehmet Bilici [...]

Journal of Oncology Pharmacy Practice

Search results